These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

135 related items for PubMed ID: 9509124

  • 1. Biological indicators of survival in patients treated by surgery for squamous cell carcinoma of the oral cavity and oropharynx.
    Veneroni S, Silvestrini R, Costa A, Salvatori P, Faranda A, Molinari R.
    Oral Oncol; 1997 Nov; 33(6):408-13. PubMed ID: 9509124
    [Abstract] [Full Text] [Related]

  • 2. Prognostic significance of Ki-67 (MIB1), PCNA and p53 in cancer of the oropharynx and oral cavity.
    Sittel C, Ruiz S, Volling P, Kvasnicka HM, Jungehülsing M, Eckel HE.
    Oral Oncol; 1999 Nov; 35(6):583-9. PubMed ID: 10705094
    [Abstract] [Full Text] [Related]

  • 3. Biological markers as indicators of pathological response to primary chemotherapy in oral-cavity cancers.
    Costa A, Licitra L, Veneroni S, Daidone MG, Grandi C, Cavina R, Molinari R, Silvestrini R.
    Int J Cancer; 1998 Dec 18; 79(6):619-23. PubMed ID: 9842971
    [Abstract] [Full Text] [Related]

  • 4. Prognostic significance of apoptosis and associated factors in oral squamous cell carcinoma.
    Stoll C, Baretton G, Ahrens C, Löhrs U.
    Virchows Arch; 2000 Feb 18; 436(2):102-8. PubMed ID: 10755598
    [Abstract] [Full Text] [Related]

  • 5. The influence of p53 and associated factors on the outcome of patients with oral squamous cell carcinoma.
    Stoll C, Baretton G, Löhrs U.
    Virchows Arch; 1998 Nov 18; 433(5):427-33. PubMed ID: 9849857
    [Abstract] [Full Text] [Related]

  • 6. Decreased expression of Bax is correlated with poor prognosis in oral and oropharyngeal carcinoma.
    Ito T, Fujieda S, Tsuzuki H, Sunaga H, Fan G, Sugimoto C, Fukuda M, Saito H.
    Cancer Lett; 1999 Jun 01; 140(1-2):81-91. PubMed ID: 10403545
    [Abstract] [Full Text] [Related]

  • 7. Association of Oral Cavity and Oropharyngeal Cancer Biomarkers in Surgical Drain Fluid With Patient Outcomes.
    Lassig AAD, Joseph AM, Lindgren BR, Yueh B.
    JAMA Otolaryngol Head Neck Surg; 2017 Jul 01; 143(7):670-678. PubMed ID: 28418447
    [Abstract] [Full Text] [Related]

  • 8. The use of clinical criteria alone in the management of the clinically negative neck among patients with squamous cell carcinoma of the oral cavity and oropharynx.
    O'Brien CJ, Traynor SJ, McNeil E, McMahon JD, Chaplin JM.
    Arch Otolaryngol Head Neck Surg; 2000 Mar 01; 126(3):360-5. PubMed ID: 10722009
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Heat shock protein and p53 expression in head and neck squamous cell carcinoma.
    Gandour-Edwards R, Trock BJ, Gumerlock P, Donald PJ.
    Otolaryngol Head Neck Surg; 1998 May 01; 118(5):610-5. PubMed ID: 9591858
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. The influence of lymph node metastasis in the treatment of squamous cell carcinoma of the oral cavity, oropharynx, larynx, and hypopharynx: N0 versus N+.
    Layland MK, Sessions DG, Lenox J.
    Laryngoscope; 2005 Apr 01; 115(4):629-39. PubMed ID: 15805872
    [Abstract] [Full Text] [Related]

  • 13. Outcomes of salvage surgery with free flap reconstruction for recurrent oral and oropharyngeal cancer.
    Kostrzewa JP, Lancaster WP, Iseli TA, Desmond RA, Carroll WR, Rosenthal EL.
    Laryngoscope; 2010 Feb 01; 120(2):267-72. PubMed ID: 20013840
    [Abstract] [Full Text] [Related]

  • 14. Predictive and prognostic markers in a series of patients with head and neck squamous cell invasive carcinoma treated with concurrent chemoradiation therapy.
    Gasparini G, Bevilacqua P, Bonoldi E, Testolin A, Galassi A, Verderio P, Boracchi P, Guglielmi RB, Pezzella F.
    Clin Cancer Res; 1995 Nov 01; 1(11):1375-83. PubMed ID: 9815934
    [Abstract] [Full Text] [Related]

  • 15. JMJD1A, H3K9me1, H3K9me2 and ADM expression as prognostic markers in oral and oropharyngeal squamous cell carcinoma.
    Maia LL, Peterle GT, Dos Santos M, Trivilin LO, Mendes SO, de Oliveira MM, Dos Santos JG, Stur E, Agostini LP, Couto CVMDS, Dalbó J, de Assis ALEM, Archanjo AB, Mercante AMDC, Lopez RVM, Nunes FD, de Carvalho MB, Tajara EH, Louro ID, Álvares-da-Silva AM.
    PLoS One; 2018 Nov 01; 13(3):e0194884. PubMed ID: 29590186
    [Abstract] [Full Text] [Related]

  • 16. Prognostic factors in salvage surgery for recurrent oral and oropharyngeal cancer.
    Agra IM, Carvalho AL, Ulbrich FS, de Campos OD, Martins EP, Magrin J, Kowalski LP.
    Head Neck; 2006 Feb 01; 28(2):107-13. PubMed ID: 16388526
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 7.